Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 14, 2017 16:30 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Reports Second Quarter 2017 Financial Results

SAN RAMON, Calif., Aug. 14, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical...
August 08, 2017 06:00 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Enters into Merger Agreement with SELLAS Life Sciences Group

Merger to create a late-stage, NASDAQ-listed company focused on developing novel immune therapies for various types of cancerSELLAS’ lead asset, galinpepimut-S (GPS), is a Wilm’s Tumor 1...
July 12, 2017 06:30 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Provides Corporate Update

SAN RAMON, Calif., July 12, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical...
May 10, 2017 16:30 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Reports First Quarter 2017 Financial Results

SAN RAMON, Calif., May 10, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical...
April 04, 2017 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Presents Positive Interim Safety Data on the NeuVax™ (nelipepimut-S) Clinical Trial in Combination with Trastuzumab in High-Risk HER2 3+ Patients at the AACR Annual Meeting 2017

SAN RAMON, Calif., April 04, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical...
March 17, 2017 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Presents Positive Final GALE-301 (E39) Phase 1/2a Clinical Trial Data

SAN RAMON, Calif., March 17, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical...
March 15, 2017 16:15 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Reports Fourth Quarter and Year End 2016 Financial Results and Provides a Corporate Update

SAN RAMON, Calif., March 15, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical...
March 09, 2017 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Engages Canaccord Genuity to Advise on Strategic Alternatives

SAN RAMON, Calif., March 09, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical...
February 21, 2017 16:10 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Board of Directors Appoints Stephen F. Ghiglieri as Interim Chief Executive Officer

SAN RAMON, Calif., Feb. 21, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical...
February 13, 2017 16:30 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Closing of Public Offering of Common Stock and Warrants

SAN RAMON, Calif., Feb. 13, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical...